news.today
Hello · Register today | LoginHello · My Account[—] [33]
UK

Oxford researchers secure £520k for haemophilia arthritis trial

Summarised from 2 outlets · Updated 15 Nov, 17:01 · Archive

Oxford University Hospitals researchers have secured £520,000 to trial a joint fluid treatment for haemophilia-related ankle arthritis.

Oxford University Hospitals has secured £520,000 from the National Institute for Health and Care Research to conduct a multicentre trial testing a new treatment for haemophilia-related ankle arthritis. The study will investigate intra-articular hyaluronic acid, sometimes referred to as 'liquid cartilage', to treat ankle arthropathy in people with haemophilia.

The trial is led by consultant haematologist Dr Nicola Curry and senior haemophilia physiotherapist Steph Taylor. Patients with haemophilia requested better treatment options in 2018, and the trial has been developed with strong support from the patient community. Dr Curry said the research would 'provide important answers to our patients' and described it as 'a truly patient-designed clinical trial'.

A pilot study in 2023 suggested that hyaluronic acid could reduce pain and improve ankle function in patients with haemophilia. The new larger, placebo-controlled trial across the UK will determine whether the treatment can consistently reduce pain, improve joint function, and enhance quality of life for patients living with haemophilic arthropathy.

Oxford researchers secure £520k for haemophilia arthritis trial
Image: Oxford Mail

Comments (0)

How it is being reported

In this story: Oxford University Hospitals · National Institute for Health and Care Research · Dr Nicola Curry · Steph Taylor · UK

This summary was written by AI from the headlines and standfirsts above, and states as fact only what at least two outlets report. How we use AI · Report a problem · Corrections log